Brain Structure vs. Function in Depression and Insomnia

Original Title: Structural rather than functional brain alterations that characterize the differences between major depressive disorder and primary insomnia: a comparative meta-analysis

Journal: BMC medicine

DOI: 10.1186/s12916-025-04442-y

Overview

Major depressive disorder (MDD) and primary insomnia (PI) share overlapping symptoms, complicating diagnosis. This study conducted a comparative meta-analysis to identify shared and distinct brain alterations in these conditions. Researchers synthesized data from 79 neuroimaging studies, including 54 on structural gray matter volume (GMV) and 25 on functional resting-state activity (ALFF). The analysis revealed common functional alterations, with both MDD and PI patients showing increased ALFF in the left temporal pole, superior temporal gyrus (STG), and right amygdala. However, no shared structural GMV abnormalities were found. A direct comparison indicated that PI patients had smaller GMV in the left striatum and median cingulate gyrus but larger GMV in the right STG compared to MDD patients. Furthermore, a meta-regression showed that symptom severity in both disorders correlated more strongly with functional (ALFF) alterations than with structural (GMV) changes.

Novelty

This study’s primary contribution is its direct, comparative meta-analysis of both structural and functional neuroimaging data for MDD and PI. By synthesizing a large body of literature, it moves beyond single-disorder studies to uncover distinguishing and overlapping neural signatures. The key finding is a dissociation between brain structure and function: shared functional hyperactivity in emotional and arousal circuits (amygdala, temporal lobe) may explain symptomatic overlap, while distinct structural differences in the striatum and cingulate gyrus differentiate the two disorders. This suggests that while moment-to-moment brain activity is similar, the underlying anatomical changes are not. The finding that symptom severity correlates with functional but not structural alterations provides evidence that functional measures may better reflect a patient's current clinical state, whereas structural changes may be more trait-like.

Potential Clinical / Research Applications

The results have clear implications for clinical work and research. Clinically, the distinct gray matter volume patterns in the striatum and cingulate gyrus could form the basis of biomarkers for differential diagnosis between MDD and PI. The shared functional hyperactivity in the amygdala and temporal regions suggests that transdiagnostic treatments targeting these circuits, such as specific neuromodulation techniques, could benefit patients with either condition.
For research, these findings justify longitudinal studies to test if functional alterations precede structural changes, clarifying the progression of these disorders. The specific brain regions identified also provide precise targets for future mechanistic studies and can serve as regions of interest in clinical trials to objectively measure treatment response.

Similar Posts

  • AI, Mobile Tech, and Social Media for Health in Africa

    Original Title: Scoping review of artificial intelligence via mobile technology and social media for health in Africa Journal: Nature communications DOI: 10.1038/s41467-025-64766-4 Overview This scoping review investigates the integration of artificial intelligence with mobile technology and social media to address health challenges in Africa. Following the PRISMA approach, researchers screened 469 articles published between 2014 and 2023, ultimately synthesizing 116 papers with a focused analysis of 29 studies. The results indicate that these digital tools are primarily utilized for infectious disease monitoring and diagnosis. Specifically, malaria was the subject of 17.2% of the studies, while COVID-19 accounted for 13.8%. Other conditions frequently studied include Ebola at 10.3%, cervical cancer at…

  • Inaction on Artificial Intelligence Regulation in a Time of Upheaval

    AI Regulation Inaction: A Health Policy Crisis One-Sentence Summary This editorial argues that the rapid advancement of AI in healthcare, combined with political upheaval paralyzing federal agencies, creates a dangerous regulatory vacuum, highlighting the urgent need for a functional public sector to establish safety guardrails. Overview This article addresses the growing gap between the rapid adoption of artificial intelligence in health and healthcare and the lagging development of governmental oversight. The author posits that the widespread availability of large language models has accelerated AI integration across all sectors. However, the policies and standards necessary to govern this technology have not kept pace. This challenge is compounded by a described period…

  • Advanced AI for Dementia Staging with MRI Imaging

    Original Title: Biomarkers Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association DOI: 10.1002/alz70856_107381 Overview Dementia represents a significant health challenge characterized by cognitive decline that interferes with daily living. Clinical diagnosis often occurs in advanced stages, necessitating early detection methods to improve patient outcomes. This study investigates deep learning algorithms to classify dementia stages using magnetic resonance imaging (MRI). The researchers utilized a dataset categorized into four stages: non-dementia, very mild, mild, and moderate dementia. A primary challenge was the significant class imbalance, with moderate dementia representing only 1% of the images. To address this, the study compared a standard six-layer convolutional neural network (CNN) against a…

  • AI-Powered Telephone Cognitive Rehabilitation for Dementia

    Original Title: Dementia Care Research and Psychosocial Factors Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association DOI: 10.1002/alz70858_098721 Overview Cognitive impairment is a significant global health challenge, affecting approximately 32% of adults over the age of 65. While cognitive rehabilitation is an established method to maintain independence and delay the need for institutional care, access remains restricted by a shortage of specialized providers. This study evaluates an automated therapy delivery system developed by Moneta Health, which utilizes an artificial intelligence-powered voice agent to provide personalized cognitive activities via telephone. The program focuses on stimulating cognitive deficits and teaching compensatory strategies. A cohort of 75 participants, with an…

  • Expert Consensus on Sonazoid CEUS for Liver Lesions

    Original Title: Expert consensus regarding the clinical application of liver contrast-enhanced US with Sonazoid (Sonazoid CEUS) Journal: International journal of surgery (London, England) DOI: 10.1097/JS9.0000000000003510 Overview This document presents an expert consensus on the clinical use of Sonazoid contrast-enhanced ultrasound for managing focal liver lesions. Sonazoid is a second-generation agent that functions as both a blood pool and a Kupffer-cell agent, with a phagocytic rate of 99 percent. Unlike pure blood-pool agents, it provides a stable post-vascular phase that lasts for approximately sixty minutes, enabling thorough liver scans. The consensus covers surveillance, diagnosis of hepatocellular carcinoma, detection of metastases, and interventional guidance. In high-risk patients, Sonazoid improves the detection of…

  • AI Model to Predict Gout Recurrence in Hospitalized Patients

    Original Title: Development and validation of a multidimensional and interpretable artificial intelligence model to predict gout recurrence in hospitalised patients: a real-world, ambispective multicentre cohort study in China Journal: BMC medicine DOI: 10.1186/s12916-025-04454-8 Overview Researchers addressed the challenge of predicting gout recurrence in hospitalized patients with other health conditions. This large, multicentre study in China included 6,526 patients in both retrospective and prospective cohorts. Using 82 clinical, laboratory, and medication features, the team developed and rigorously tested 3,744 different artificial intelligence models to find the most accurate and reliable one. The final selected model, a Gradient Boosting algorithm, demonstrated good predictive performance. It achieved an area under the curve (AUC)…

Leave a Reply

Your email address will not be published. Required fields are marked *

CAPTCHA